Medistim ASA (OSL:MEDI)

Market Cap	5.19B
Revenue (ttm)	662.18M
Net Income (ttm)	142.42M
Shares Out	18.27M
EPS (ttm)	7.79
PE Ratio	36.46
Forward PE	31.91
Dividend	6.00 (2.20%)
Ex-Dividend Date	May 9, 2025

Volume	14,392
Average Volume	40,286
Open	275.00
Previous Close	273.00
Day's Range	275.00 - 292.00
52-Week Range	130.00 - 292.00
Beta	1.04
RSI	76.87
Earnings Date	Apr 9, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Oslo Børs
• Ticker Symbol: MEDI

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.